Skip to main content
↑

Events

Recordati Sponsored Webinar - Search, Identify, Treat: Managing Residual CV Risk in Primary Care

Recordati Sponsored Webinar - Search, Identify, Treat: Managing Residual CV Risk in Primary Care

Download Event to Calendar

This session is sponsored by Recordati Pharmaceuticals Limited. PCCS have received sponsorship from Recordati Pharmaceuticals Limited for this presentation. The content has been developed independently by PCCS. Recordati Pharmaceuticals Limited have reviewed the content and associated documentation for accuracy and compliance with the ABPI Code of Practice.

Click here for VAZKEPA®▼ (ICOSAPENT ETHYL) prescribing information and adverse event reporting information. 


 

The Primary Care Cardiovascular Society (PCCS) invites you to attend the Search, Identify, Treat: Managing Residual Cardiovascular Risk in Primary Care webinar on Tuesday, 3rd November 2026, from 19:00-21:00.
Elevated triglycerides are a well-established risk factor for developing cardiovascular disease (CVD), yet they often go under-recognised in routine practice. Identifying at-risk patients early is essential for timely diagnosis, effective management and to support positive long-term patient outcomes.
Join Prof Raj Thakkar, Meredith Donaldson and Beverley Bostock as they demonstrate how to implement targeted system searches within your clinical software to systematically identify patients with raised triglycerides - including those who may otherwise go unidentified and untreated. You will come away with practical learns and search strategies you can apply in your own practice immediately.
We look forward to seeing you there.

 

This session is sponsored by Recordati Pharmaceuticals Limited. PCCS have received sponsorship from Recordati Pharmaceuticals Limited for this presentation. The content has been developed independently by PCCS. Recordati Pharmaceuticals Limited have reviewed the content and associated documentation for accuracy and compliance with the ABPI Code of Practice.

Click here for VAZKEPA®▼ (ICOSAPENT ETHYL) prescribing information and adverse event reporting information. 


 

Agenda

Tuesday 3rd November 2026

19:00

Welcome and introduction​


19:05

Reducing residual risk: Insights and clinical application

  • Speaker: Prof Raj Thakkar

19:35

Practical tips for finding and managing high-risk patients

  • Speaker: Beverley Bostock

19:55

Q&A


20:10

From data to diagnosis: Finding patients with elevated triglycerides in your system

  • Speaker: Meredith Donaldson

20:40

Panel Q&A Session


20:55

Closing remarks


Agenda subject to change

This session is sponsored by Recordati Pharmaceuticals Limited. PCCS have received sponsorship from Recordati Pharmaceuticals Limited for this presentation. The content has been developed independently by PCCS. Recordati Pharmaceuticals Limited have reviewed the content and associated documentation for accuracy and compliance with the ABPI Code of Practice.

Click here for VAZKEPA®▼ (ICOSAPENT ETHYL) prescribing information and adverse event reporting information. 


 

Speakers

Prof Raj Thakkar

Prof Raj Thakkar

PCCS Past President and CKD representative

Raj trained at UCL and in the Oxford Deanery. His varied roles include GP partner since 2004, primary care cardiology lead for the Oxford Health Innovation Network and national primary care workstream co-lead for the cardiac transformation programme (NHSE). He is also on the national expert advisory groups for lipids, heart attack and heart failure. Raj is the Past President of the Primary Care Cardiovascular Society, Honorary Visiting Professor at Cardiff University Medical School and Anglia Ruskin University, Cambridge. Previous roles included Clinical Commissioning Director for Bucks CCG/BOB ICB, Cardiac Lead for the TV Strategic Clinical Network, and atrial fibrillation champion for NHSIQ Thames Valley. Raj has worked as a presenter on BBC Radio and is a medical writer, speaker, and advisor. He has written and published over 200 articles and several books including the MIMS consultation guide (BMA book of the year, Medicine, 2012). 


Beverley Bostock

Beverley Bostock

PCCS President, Advanced Nurse Practitioner, Mann Cottage Surgery and Editor in Chief, Practice Nurse Journal

Beverley is an Advanced Nurse Practitioner in long-term conditions. She is currently President of the Primary Care Cardiovascular Society.  She has a special interest in cardiovascular disease (CVD), diabetes, heart failure, chronic kidney disease and lipid management along with common comorbidities such as metabolic liver disease, asthma and COPD. She is Editor-in-Chief of Practice Nurse Journal and has been a Queen’s Nurse since 2015. In a previous role she developed and delivered accredited modules in cardiovascular disease, heart failure and diabetes in collaboration with the Open University. As well as holding an MA in Medical Ethics and Law and an MSc in Respiratory Care, Bev has a Postgraduate Diploma in Diabetes from the University of Warwick. Bev has had an extensive range of articles published in various journals on the management of long-term conditions and is a regular speaker at national conferences.


Dr Meredith Donaldson

Dr Meredith Donaldson

PCCS Treasurer & Physician Associate

Meredith Donaldson is a highly skilled Physician Associate currently practicing in a rural primary care setting in East Lincolnshire. She holds a Master’s degree in Physician Assistant Studies from the United States, where she initially specialised in Obstetrics and Gynaecology in California. Since relocating to the UK over four years ago, Meredith has further advanced her expertise by obtaining a Diploma in Improving Diabetes Care and completing a second Master’s degree in Long-term Conditions, with a particular focus on respiratory and cardiovascular health. Her commitment to delivering comprehensive and compassionate care is central to her practice.

Meredith is also deeply engaged in the fields of medical education and research. She has delivered presentations at various educational events, produced numerous abstracts and presentations for international conferences, and served as a preceptor for Physician Associates in training. In her current role, she leads hyperlipidaemia management at her practice. Additionally, Meredith has co-authored several published articles and has recently completed a PhD in CVD and COPD, further contributing to her field’s body of knowledge.

This session is sponsored by Recordati Pharmaceuticals Limited. PCCS have received sponsorship from Recordati Pharmaceuticals Limited for this presentation. The content has been developed independently by PCCS. Recordati Pharmaceuticals Limited have reviewed the content and associated documentation for accuracy and compliance with the ABPI Code of Practice.

Click here for VAZKEPA®▼ (ICOSAPENT ETHYL) prescribing information and adverse event reporting information. 


 

Prices

This event is free for all delegates.

This session is sponsored by Recordati Pharmaceuticals Limited. PCCS have received sponsorship from Recordati Pharmaceuticals Limited for this presentation. The content has been developed independently by PCCS. Recordati Pharmaceuticals Limited have reviewed the content and associated documentation for accuracy and compliance with the ABPI Code of Practice.

Click here for VAZKEPA®▼ (ICOSAPENT ETHYL) prescribing information and adverse event reporting information. 


 

Delegate Terms and Conditions

Data Protection

The personal data you provide when registering for this conference will be used by LCW Consulting Ltd to administer and manage the event. For attendance reporting purposes, we will share your name, organisation, job title, and location with PCCS, the event speakers, and the event sponsor. This sharing is based on the legitimate interests of LCW Consulting Ltd, PCCS, the event speakers, and the event sponsor in delivering and evaluating the conference (see declaration). If you wish to cancel your registration, change your options, or require further information on our data protection policies, please email registrations@lcwmed.co.uk or call via the registration number 0330 174 1090.

Changing Delegate Details

There will be no charge if a substitute person wishes to replace the original delegate. Please inform our office at registrations@lcwmed.co.uk of any change to the original booking.

Event Cancellation Policy

The PCCS' courses are constantly updated and improved and the PCCS reserves the right to alter any of the courses’ content without prior notice. The PCCS reserves the right to cancel a course at any time without liability. In these circumstances, delegates will be offered an alternative date if possible.

Cancellation Of Registration

The PCCS reserve the right to cancel or refuse any registration at our sole discretion if the registrant does not meet the eligibility or participation criteria. In such cases, any registration fees paid will be refunded; however, we will not be responsible for, nor will we reimburse, any costs incurred for travel, accommodation, or other related expenses. 

 

 

 

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/​

Adverse events should also be reported to Recordati Pharmaceuticals Limited by e-mail: Local-Safety@recordati.com or by calling +44 (0)1491 576 336​

 

UK-VAZK-0257 | August 2026

Other events